Sign in
4

Changes in Ownership

Spero Therapeutics, Inc. Filed Acc 0000950170-24-101998

Chief Operating Officer sold 2,213 shares at $1.35 ($2,988)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Keutzer Timothy Chief Operating Officer 2024-08-27 Sale −2,213 $1.35 $2,988 531,837 D
Open-market sales · 2,213 sh · avg $1.35 · $2,988
Loading xslF345X05/ownership.xml…